EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance

Alice Köhli-Wiesner, Lisbeth Stahlberger, Christian Bieli, Tamar Stricker, Roger Lauener

Journal of Allergy · 19.07.2012 · 2012 · 1-5

DOI: 10.1155/2012/790910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy, erschienen am 19.07.2012. Verfasst von Alice Köhli-Wiesner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Christine Kühne-Center for Allergy Research and Education, University Children's Hospital Zurich, Steinwiesstraße 75, 8032 Zurich, Switzerland. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Objective. Ultrarush induction for specific venom immunotherapy has been shown to be reliable and efficacious in adults. In this study its safety and tolerance in children was evaluated.

Methods

Retrospective analysis of 102 ultrarush desensitizations carried out between 1997 and 2005 in 94 children, aged 4 to 15 years. Diagnosis and selection for immunotherapy were according to recommendations of the European Academy of Allergy and Clinical Immunology. Systemic adverse reactions (SARs) were described using the classification of H. L. Mueller.

Results

All patients reached the cumulative dose of 111.1 μ g hymenoptera venom within 210 minutes. Six patients (6%) had allergic reactions grade I; 2 patients (2%) grade II and 5 patients (5%) grade III. Three patients (3%) showed unclassified reactions. SARs did not occur in the 15 patients aged 4 to 8 years and they were significantly more frequent in girls (29%) compared with boys (12%) (, multivariant analysis) and in bee venom extract treated patients (20%) compared to those treated with wasp venom extract (8%) (OR 0.33, 95% Cl 0.07–1.25).

Conclusion

Initiation of specific immunotherapy by ultrarush regimen is safe and well tolerated in children and should be considered for treating children with allergy to hymenoptera venom.

Autor:innen und Institutionen

  • Christine Kühne-Center for Allergy Research and Education, University Children's Hospital Zurich, Steinwiesstraße 75, 8032 Zurich, Switzerland.

Zitieren

APA

Köhli-Wiesner, A., Stahlberger, L., Bieli, C., Stricker, T., & Lauener, R. (2012). Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance. Journal of Allergy, 2012, 1-5. https://doi.org/10.1155/2012/790910

Vancouver

Köhli-Wiesner A, Stahlberger L, Bieli C, Stricker T, Lauener R. Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance. Journal of Allergy. 2012;2012:1-5. doi:10.1155/2012/790910

BibTeX
@article{KhliWiesner2012,
  author = {Köhli-Wiesner, Alice and Stahlberger, Lisbeth and Bieli, Christian and Stricker, Tamar and Lauener, Roger},
  title = {Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance},
  journal = {Journal of Allergy},
  year = {2012},
  volume = {2012},
  pages = {1--5},
  doi = {10.1155/2012/790910}
}
Kostenlos starten →